Deerfield Management’s ESSA Pharma EPIX Stock Holding History

Deerfield Management’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-70,812	Closed	-$779K	–	94
2017 Q2	$779K	Sell	70,812 -35,268	-33%	-$1.15M	0.04%	84
2017 Q1	$6.62M	Hold	106,080	–	–	0.26%	81
2016 Q4	$4.65M	Hold	106,080	–	–	0.19%	78
2016 Q3	$5.83M	Sell	106,080 -1,778	-2%	-$95K	0.27%	58
2016 Q2	$6.36M	Sell	107,858 -21,503	-17%	-$1.34M	0.25%	66
2016 Q1	$8.41M	Buy	129,361 +36,397	+39%	+$2.37M	0.36%	62
2015 Q4	$8.5M	Hold	92,964	–	–	0.34%	67
2015 Q3	$11.6M	Buy	+92,964	New	+$13M	0.45%	69

Other funds holding EPIX

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Deerfield Management's EPIX Position: Q3 2017 in Review

Deerfield Management sold out of ESSA Pharma (EPIX) in Q3 2017, closing a stake of 70,812 shares — an estimated $779K sold.

Deerfield Management first reported a position in EPIX in Q3 2015 and held it in 8 quarters. The position peaked at $11.6M in Q3 2015. 10 funds tracked by Wall St. Rank hold EPIX as of Q3 2017.

Deerfield Management reported no remaining ESSA Pharma position as of Q3 2017 after selling out during the quarter.
Deerfield Management sold 70,812 ESSA Pharma shares in Q3 2017, an estimated $779K.
Deerfield Management first reported a position in ESSA Pharma in Q3 2015 and held it in 8 quarters.
Deerfield Management's ESSA Pharma position peaked at $11.6M in Q3 2015.
10 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2017.

Based on Deerfield Management's 13F filing for Q3 2017, filed 13 Nov 2017.